“The United States needs resilient, diverse, and secure supply chains to help ensure economic prosperity and national security,” said Assistant Secretary for Preparedness and Response Dawn O’Connell. “We are committed to doing what we can do ensure the U.S. active pharmaceutical ingredient (API) supply chain is secure and resilient, so essential medicines are available in emergencies such as pandemics. APIs must be manufactured domestically and readily available to make medicines, especially during emergencies.”
Access the full press release to learn more.